Provided by Tiger Trade Technology Pte. Ltd.

Actinium Pharmaceuticals

1.10
-0.0200-1.79%
Post-market: 1.100.00000.00%19:30 EDT
Volume:144.01K
Turnover:161.77K
Market Cap:34.51M
PE:3.09
High:1.14
Open:1.13
Low:1.10
Close:1.12
52wk High:1.81
52wk Low:0.7351
Shares:31.37M
Float Shares:31.25M
Volume Ratio:0.53
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3559
EPS(LYR):-1.0900
ROE:45.86%
ROA:11.58%
PB:1.14
PE(LYR):-1.01

Loading ...

A Bitcoin Miner Just Borrowed $573M to Chase AI

FilingAlpha
·
Aug 17

Actinium Pharmaceuticals Expands Actimab-A Patents, Manufacturing Capacity

TIPRANKS
·
Aug 15

Actinium Pharma Says Two US Actimab-a Patents Issued for Solid Tumor Treatment Through 2043

Reuters
·
Aug 15

Actinium Pharmaceuticals - Amends Ind to Add Manufacturer for Crada and Company Studies; Milestones Expected H2 2026-2027

THOMSON REUTERS
·
Aug 15

Actinium Pharmaceuticals Announces Actimab-a Intellectual Property and Manufacturing Advances and Provides NYSE American Listing Update

THOMSON REUTERS
·
Aug 15

Actinium Pharmaceuticals Q2 EPS $0.89 Beats $(0.21) Estimate, Sales $35.000M

Benzinga Earnings
·
Aug 12

Actinium Swings to Q2 FY26 Net Income of $27.9 Million; Revenue Turns to $35 Million

Reuters
·
Aug 08

Actinium Pharmaceuticals submits NYSE American compliance plan after falling below $4 million equity threshold

Reuters
·
Jun 19

Actinium presented preclinical data on ATNM-400 in NSCLC at SNMMI 2026

TIPRANKS
·
Jun 03

Actinium says ATNM-400 beats approved androgen receptor inhibitors in resistant prostate cancer models at SNMMI 2026

Reuters
·
Jun 03

Actinium Pharmaceuticals names Steffen Heeger chief medical officer

Reuters
·
Jun 01

Actinium Appoints Accomplished Oncology Expert Steffen Heeger Md, MSC as Chief Medical Officer to Drive Rejuvenated Pipeline Development

THOMSON REUTERS
·
Jun 01

Press Release: Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development

Dow Jones
·
Jun 01

Actinium Pharma presents SNMMI data showing CAR optimization improves tumor targeting of actinium-225 radioconjugates

Reuters
·
Jun 01

Actinium Highlights New ATNM-400 Data Amid Listing Pressure

TIPRANKS
·
May 30

Actinium Pharmaceuticals Gets Canadian Approval for Two Patents

Dow Jones
·
May 30

Actinium Pharmaceuticals receives two patent allowances from CIPO

TIPRANKS
·
May 30

Actinium Pharmaceuticals - Receives Two Canadian Patent Allowances for Actimab-a and Iomab-Act Programs

THOMSON REUTERS
·
May 30

Actinium Pharma wins Canadian patent allowances for Actimab-A, Iomab-ACT programs

Reuters
·
May 30

Actinium gets NYSE American notice for failing $4 million stockholders’ equity listing standard

Reuters
·
May 30